-transparent.png){kind=logo}
It has been assumed that uremic parathyroid hyperplasia predominantly involves generalized polyclonal cellular proliferation, because of multigland involvement. However, the majority of uremic hyperplasias resected from patients with secondary hyperparathyroidism are monoclonal. The specific acquired genetic abnormalities would have a great role in providing this selective advantage of the parathyroid hyperplasia.
| UI | MeSH Term | Description | Entries |
|---|
Related Publications
Yasuo Imanishi, and
Keisuke Kobayashi
February 2009,
The International journal of artificial organs,
Yasuo Imanishi, and
Keisuke Kobayashi
December 1999,
Kidney international. Supplement,
Yasuo Imanishi, and
Keisuke Kobayashi
January 1995,
Mineral and electrolyte metabolism,
Yasuo Imanishi, and
Keisuke Kobayashi
February 1994,
American journal of kidney diseases : the official journal of the National Kidney Foundation,
Yasuo Imanishi, and
Keisuke Kobayashi
January 1996,
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association,
Yasuo Imanishi, and
Keisuke Kobayashi
January 1997,
Kidney & blood pressure research,
Yasuo Imanishi, and
Keisuke Kobayashi
April 2006,
Journal of renal nutrition : the official journal of the Council on Renal Nutrition of the National Kidney Foundation,
Yasuo Imanishi, and
Keisuke Kobayashi
April 1991,
The Journal of clinical endocrinology and metabolism,
Yasuo Imanishi, and
Keisuke Kobayashi
January 2005,
Journal of nephrology,
Yasuo Imanishi, and
Keisuke Kobayashi
January 1986,
Nephron,
